Whole-Genome mRNA Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme

CNS Neuroscience and Therapeutics

Volumn 19, Issue 9, 2013, Pages 714-720

  Bao, Zhao Shi ^a   Zhang, Chuan Bao ^a   Wang, Hong Jun ^b   Yan, Wei ^a   Liu, Yan Wei ^a   Li, Ming Yang ^a   Zhang, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Glioblastoma; Mesenchymal; Prognosis; Risk score

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; GLIOBLASTOMA; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

BIOMARKER; GLIOBLASTOMA; MESENCHYMAL; PROGNOSIS; RISK SCORE;

BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER;

EID: 84882882501     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12118     Document Type: Article

References (29)

1. Wang Y, Jiang T. Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management. Cancer Lett 2013;331:139-146.
2. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
3. Yan W, Zhang W, You G, et al. Molecular classification of gliomas based on whole genome gene expression: A systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 2012;14:1432-1440.
4. Hanzelmann S, Castelo R, Guinney J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 2013;14:7.
5. Su K, Kyaw H, Fan P, et al. Isolation, characterization, and mapping of two human potassium channels. Biochem Biophys Res Commun 1997;241:675-681.
6. Lubec G, Sohn SY. RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain. J Neural Transm Suppl 2003;215-224.
7. Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011;1:161.
8. Thelen K, Jaehrling S, Spatz JP, Pollerberg GE. Depending on its nano-spacing, ALCAM promotes cell attachment and axon growth. PLoS ONE 2012;7:e40493.
9. Iolyeva M, Karaman S, Willrodt AH, Weingartner S, Vigl B, Halin C. Novel role for ALCAM in lymphatic network formation and function. FASEB J 2013;27:978-990.
10. Carbotti G, Orengo AM, Mezzanzanica D, et al. Activated leukocyte cell adhesion molecule soluble form: A potential biomarker of epithelial ovarian cancer is increased in type II tumors. Int J Cancer 2012;132:2597-2605.
11. Chaker S, Kak I, MacMillan C, Ralhan R, Walfish PG. Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival. Thyroid 2013;23:201-208.
12. Federman N, Chan J, Nagy JO, et al. Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor. Sarcoma 2012;2012:126906.
13. Ishiguro F, Murakami H, Mizuno T, et al. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer. J Surg Res 2013;179:24-32.
14. Jiao J, Hindoyan A, Wang S, et al. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS ONE 2012;7:e42564.
15. Volk DW, Matsubara T, Li S, et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry 2012;169:1082-1091.
16. Neves G, Shah MM, Liodis P, et al. The LIM Homeodomain Protein Lhx6 Regulates Maturation of Interneurons and Network Excitability in the Mammalian Cortex. Cereb Cortex 2012; doi: 10.1093/cercor/bhs159.
17. Zhang Z, Gutierrez D, Li X, et al. The LIM Homeodomain Transcription Factor LHX6: A Transcriptional Repressor That Interacts With pituitary homeobox 2 (PITX2) to regulate odontogenesis. J Biol Chem 2013;288:2485-2500.
18. Jung S, Jeong D, Kim J, et al. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer. Int J Oncol 2011;38:859-869.
19. Estecio MR, Youssef EM, Rahal P, et al. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 2006;25:5018-5026.
20. Blanco MA, LeRoy G, Khan Z, et al. Global secretome analysis identifies novel mediators of bone metastasis. Cell Res 2012;22:1339-1355.
21. Wiech T, Nikolopoulos E, Weis R, et al. Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. Lab Invest 2009;89:385-397.
22. Yamano Y, Ohyama K, Sano T, et al. A novel spermatogenesis-related factor-1 gene expressed in maturing rat testis. Biochem Biophys Res Commun 2001;289:888-893.
23. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-173.
24. Li A, Walling J, Ahn S, et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 2009;69:2091-2099.
25. Zhang W, Zhang J, Yan W, et al. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer 2013;119:814-824.
26. Noushmehr H, Weisenberger DJ, Diefes K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010;17:510-522.
27. Zhang W, Yan W, You G, et al. Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer Lett 2013;328:120-125.
28. Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009;1:a003129.
29. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004;4:118-132.